Further research indicated that the oncogene BCR-ABL, responsible for chronic myeloid leukemia (CML), has been shown to upregulate the expression and activity of SMS in CML cell lines [26]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.